You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The tests were developed by Psomagen, Acupath Laboratories, and BioTNS, and the nasal swab self-collection kit is offered by Kroger Health.
The Korean company said it plans to use equipment and reagents from Thermo Fisher and to expand its overseas markets for CE sequencing services.
The project has sequenced more than 1,700 individuals from across Asia to high coverage in order to bolster the representation of Asians in genomic research.
Microba offers a direct-to-consumer service that uses shotgun metagenomics to analyze customers' gut microbiomes and generate a personalized report.
The companies signed an agreement earlier this year to jointly develop microbiome research services for international markets including a shotgun metagenomic sequencing-based service.
The designation will enable the South Korea-based squencing services provider to perform NGS analysis of clinical trial samples.
The South Korean companies have also agreed to work together on the development of exosome-based biomedical products including diagnostics and therapeutics.
The companies will initially work on a shotgun metagenomic sequencing-based service for microbiome research that will be offered internationally.
South Korea-based Macrogen has acquired a a non-exclusive research tool license to CRISPR-Cas9 technology.
The company, a spinoff from genomics service provider Macrogen, plans to offer patients an exome test that screens for more than 4,000 rare diseases.
Novavax has begun a phase III trial of its SARS-CoV-2 vaccine, according to the New York Times.
Vox reports that the Trump Administration may limit student visas for individuals from some countries to two years.
The governor of New York says the state will conduct its own review of any SARS-CoV-2 vaccine, NPR reports.
This week in Science: Neanderthal Y chromosomes replaced by Homo sapiens Y chromosomes, and more.